What Happens After Stopping GLP-1 Medications? What the Research Shows
Key Takeaways GLP-1-based medications can be effective tools for chronic weight management when appropriately prescribed and monitored. Clinical trials have found weight regain after semaglutide or tirzepatide was discontinued, but the amount varied by study and should not be treated as an individual prediction. The frequently cited “two-thirds” figure comes from a specific semaglutide study, not from every GLP-1 medication or every patient. Weight management is influenced by medication effects, biology, nutrition, physical activity, sleep, stress, health conditions, routines, and ongoing support. Treatment duration is an individual clinical decision. Planning for follow-up and long-term weight management should begin before treatment changes—not after. What Clinical Trials Tell Us About Weight Regain One of the most frequently cited findings comes from the STEP 1 extension study involving semaglutide 2.4 mg. Participants had lost an average of 17.3% of their starting body weight afte...